These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31136054)

  • 1. High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma.
    Harkin T; Elhage O; Chandra A; Khan N; Kiberu Y; Frydenberg M; Dasgupta P
    BJU Int; 2019 Dec; 124(6):907-909. PubMed ID: 31136054
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
    Murata Y; Tatsugami K; Yoshikawa M; Hamaguchi M; Yamada S; Hayakawa Y; Ueda K; Momosaki S; Sakamoto N
    Int J Urol; 2018 Mar; 25(3):284-289. PubMed ID: 29315854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate ductal adenocarcinoma exhibiting a late recurrence in the anterior urethra 13 years post-total prostatectomy: a case report.
    Honda S; Kawahara T; Tanaka R; Yuguchi S; Yamanaka S; Fujii S; Hasizume A; Osaka K; Mimura N; Karibe J; Noguchi T; Shimokihara K; Takamoto D; Takeshima T; Teranishi JI; Makiyama K; Uemura H
    J Med Case Rep; 2024 Aug; 18(1):371. PubMed ID: 39152479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
    Samaratunga H; Duffy D; Yaxley J; Delahunt B
    Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
    Chow K; Bedő J; Ryan A; Agarwal D; Bolton D; Chan Y; Dundee P; Frydenberg M; Furrer MA; Goad J; Gyomber D; Hanegbi U; Harewood L; King D; Lamb AD; Lawrentschuk N; Liodakis P; Moon D; Murphy DG; Peters JS; Ruljancich P; Verrill CL; Webb D; Wong LM; Zargar H; Costello AJ; Papenfuss AT; Hovens CM; Corcoran NM
    Eur J Cancer; 2021 May; 148():440-450. PubMed ID: 33678516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.
    Trudel D; Downes MR; Sykes J; Kron KJ; Trachtenberg J; van der Kwast TH
    Eur J Cancer; 2014 Jun; 50(9):1610-6. PubMed ID: 24703897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prostatic central zone adenocarcinoma.
    Mai KT; Belanger EC; Al-Maghrabi HM; Robertson S; Wang D; Margnean C
    Pathol Res Pract; 2008; 204(4):251-8. PubMed ID: 18178014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate.
    Jang WS; Shin SJ; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Cho NH; Choi YD
    J Urol; 2017 Apr; 197(4):1048-1053. PubMed ID: 27916712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal carcinoma of the prostate in the ejaculatory duct.
    Sanchez-Salazar AJ; Basler JW; Nicolas MM
    Int J Surg Pathol; 2010 Aug; 18(4):298-9. PubMed ID: 20444733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor].
    Finamanti M; Antonelli A; Contessa P; Cosciani Cunico S; Simeone C
    Urologia; 2011; 78(4):283-7. PubMed ID: 22139802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cystic ductal carcinoma of the prostate: imaging findings and minimally invasive surgical treatment.
    Torricelli FC; Tucherman M; Melogno R; Coelho RF
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432907
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
    Lucan M; Vasiliu V; Iacob G; Lucan V
    Chirurgia (Bucur); 2009; 104(3):355-8. PubMed ID: 19601472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
    Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
    APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
    Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
    Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal adenocarcinoma of the prostate.
    Shazer RL; Luthringer D; Agus DB; Gross ME
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):393-5; discussion 396. PubMed ID: 16163211
    [No Abstract]   [Full Text] [Related]  

  • 19. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
    Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.